For patients with advanced oropharyngeal cancer, proton therapy may beat photon radiotherapy in terms of overall survival and toxicity. Medscape Medical News
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
Hearts of Younger Athletes Adapt More to Endurance Training
Hearts of young cyclists show greater exercise-related adaptation, including more left ventricular enlargement and changes on heart tests, than those of master cyclists. Medscape News UK
-
Woman Develops Osteoradionecrosis After Breast Reirradiation
Delayed musculoskeletal symptoms after breast radiotherapy can reflect osteoradionecrosis rather than recurrence, thus supporting a structured conservative management approach. Medscape UK
-
Can Radiotherapy Improve Immunotherapy Outcomes in SCLC?
The addition of consolidative thoracic radiotherapy to chemoimmunotherapy is associated with improved survival among patients with extensive-stage small cell lung cancer. Medscape Medical News
-
PET and MRI for Re-Irradiation Therapy Show Similar Outcomes
O-(2-[18F]Fluoroethyl)-L-tyrosine-PET-based delineation yields similar clinical outcomes to contrast-enhanced T1-weighted MRI for re-irradiation in patients with glioblastoma. Medscape News UK
-
Adding Radiotherapy to TACE May Improve Early HCC Survival
First-line transarterial chemoembolization combined with radiotherapy is associated with improved survival among patients with early-stage hepatocellular carcinoma. Medscape Medical News
-
Fever During Pregnancy: Step-by-Step Guide for What to Do
Sepsis scores are not validated in pregnancy; delays increase mortality. If intrauterine infection is suspected, induce delivery and start antibiotics. Medscape News Europe
-
Can Dual-Energy CT Replace Standard Imaging in GI Bleeding?
A retrospective single-centre study finds that a dual-energy CT protocol is non-inferior to a conventional triphasic CT protocol in diagnosing gastrointestinal bleeding. Medscape News UK
-
SBRT Delays Systemic Therapy in Oligometastatic Cancers
For patients with oligometastatic cancers, particularly kidney or prostate, stereotactic body radiotherapy may frequently delay the need for systemic therapy for at least 1 year. Medscape Medical News
-
EGFR Combo Helps but Misses Today’s First-Line Needs
Dr Mark Kris breaks down the lazertinib-amivantamab data, noting that the combo shows benefit but fails to address key first-line questions clinicians face in today’s landscape. Medscape Oncology